Note: If you intend to rely on any legislation referred to on this website, you should access copies of the official versions on the Attorney General's Department's ComLaw website, which incorporates the Federal Register of Legislative Instruments (FRLI). Instruments are amended from time to time and may, on occasions, be replaced or new instruments made.
Section 16(1) and (1A) of the Therapeutics Goods Act 1989 list the differences that result in goods being considered separate and distinct from other goods.
Some therapeutic goods are considered to be in a 'gazetted therapeutic goods group'. Gazetted therapeutic goods groups are determined by orders published in the Gazette.
However, individual products within the group remain separate and distinct products under section 16(1) and (1A).